Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Bioanalytical Systems

Bioanalytical Systems
1974 FOUNDED
PUBLIC STATUS
201-300 EMPLOYEES
BASI STOCK SYMBOL
1 INVESTMENTS
$2.03 SHARE PRICE (As of Thursday Closing)
Description

Bioanalytical Systems Inc is a contract research organization which provides drug discovery and development services and analytical instruments. The company operates in two business segments namely contract research services and research products. The contract research services segment provides research and development support on a contract basis directly to pharmaceutical companies. In addition, it also includes services to screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance and quality control testing. The research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers, and medical research institutions.

Website
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Commercial Services
Stock Exchange
NAS
Primary Office
  • 2701 Kent Ave
  • West Lafayette, IN 47906
  • United States

+1 (317) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Bioanalytical Systems’s full profile, request a free trial.

Bioanalytical Systems Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.18 - $2.59 $20.9M $2.01 -$0.03 20.4K 10.3M

Bioanalytical Systems Financials Summary

In Thousands,
USD
TTM
31-Dec-2018
FY 2018
30-Sep-2018
FY 2017
30-Sep-2017
FY 2016
30-Sep-2016
Enterprise Value 15,916 21,527 20,991 15,005
Revenue 29,594 26,346 24,242 20,441
EBITDA 2,235 1,895 2,963 (1,289)
Net Income (305) (194) 884 (3,230)
Total Assets 30,903 31,268 20,417 21,129
Total Debt 9,316 9,579 4,579 5,338
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Bioanalytical Systems Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Bioanalytical Systems‘s full profile, request access.

Request full access to PitchBook

Bioanalytical Systems Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000 00000 02-Jul-2018 000000000000000000 000 Drug Discovery 0000 00000000
To view this company’s complete investment and acquisition history, request access »

Bioanalytical Systems Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000 00000 Drug Discovery Maryland Heights, MO 0000
To view this company’s complete subsidiary history, request access »

Bioanalytical Systems Executive Team (5)

Name Title Board
Seat
Contact
Info
Jill Blumhoff Chief Financial Officer & Vice President, Finance
Dawn Joseph Director, Business Development
Peter Kissinger Ph.D Founder

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »